Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes von Tushuizen, Maarten E, Bunck, Mathijs C, Pouwels, Petra J, Bontemps, Saskia, van Waesberghe, Jan Hein T, Schindhelm, Roger K, Mari, Andrea, Heine, Robert J, Diamant, Michaela

Volltext

Tirzepatide Once Weekly for the Treatment of Obesity von Jastreboff, Ania M., Aronne, Louis J., Ahmad, Nadia N., Wharton, Sean, Connery, Lisa, Alves, Breno, Kiyosue, Arihiro, Zhang, Shuyu, Liu, Bing, Bunck, Mathijs C., Stefanski, Adam

Volltext

Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition von Bunck, Mathijs C, Diamant, Michaela, Eliasson, Bjorn, Cornér, Anja, Shaginian, Rimma M, Heine, Robert J, Taskinen, Marja-Riitta, Yki-Järvinen, Hannele, Smith, Ulf

Volltext

Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men von van Raalte, Daniël H, Nofrate, Valentina, Bunck, Mathijs C, van Iersel, Thijs, Elassaiss Schaap, Jeroen, Nässander, Ulla K, Heine, Robert J, Mari, Andrea, Dokter, Wim H A, Diamant, Michaela

Volltext

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial von Wadden, Thomas A., Chao, Ariana M., Machineni, Sriram, Kushner, Robert, Ard, Jamy, Srivastava, Gitanjali, Halpern, Bruno, Zhang, Shuyu, Chen, Jiaxun, Bunck, Mathijs C., Ahmad, Nadia N., Forrester, Tammy

Volltext

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis von Loomba, Rohit, Hartman, Mark L., Lawitz, Eric J., Vuppalanchi, Raj, Boursier, Jérôme, Bugianesi, Elisabetta, Yoneda, Masato, Behling, Cynthia, Cummings, Oscar W., Tang, Yuanyuan, Brouwers, Bram, Robins, Deborah A., Nikooie, Amir, Bunck, Mathijs C., Haupt, Axel, Sanyal, Arun J.

Volltext

Incretin mimetics as a novel therapeutic option for hepatic steatosis von Tushuizen, Maarten E., Bunck, Mathijs C., Pouwels, Petra J., Van Waesberghe, Jan Hein T., Diamant, Michaela, Heine, Robert J.

Volltext

Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program von Roux, Carel W., Zhang, Shuyu, Aronne, Louis J., Kushner, Robert F., Chao, Ariana M., Machineni, Sriram, Dunn, Julia, Chigutsa, Farai B., Ahmad, Nadia N., Bunck, Mathijs C.

Volltext

Weight reduction and the impact on apnea-hypopnea index: A systematic meta-analysis von Malhotra, Atul, Heilmann, Cory R., Banerjee, Kushal K., Dunn, Julia P., Bunck, Mathijs C., Bednarik, Josef

Volltext

Long-Term Treatment of Transsexuals with Cross-Sex Hormones: Extensive Personal Experience von Gooren, Louis J., Giltay, Erik J., Bunck, Mathijs C.

Volltext

Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients von BUNCK, Mathijs C., POELMA, Marieke, EEKHOFF, E. Marelise, SCHWEIZER, Anja, HEINE, Robert J., NIJPELS, Giel, FOLEY, James E., DIAMANT, Michaela

Volltext

Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity von van der Pouw Kraan, Tineke C T M, Chen, Weena J, Bunck, Mathijs C M, van Raalte, Daniel H, van der Zijl, Nynke J, van Genugten, Renate E, van Bloemendaal, Liselotte, Baggen, Josefien M, Serné, Erik H, Diamant, Michaela, Horrevoets, Anton J G

Volltext

Fifty-two-Week Treatment With Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycemic Control in Men With Newly Diagnosed Type 2 Diabe... von Heufelder, Armin E, Saad, Farid, Bunck, Mathijs C, Gooren, Louis

Volltext

Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes von Bunck, Mathijs C, Cornér, Anja, Eliasson, Bjorn, Heine, Robert J, Shaginian, Rimma M, Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Diamant, Michaela

Volltext

Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial von Malhotra, Atul, Bednarik, Josef, Chakladar, Sujatro, Dunn, Julia P., Weaver, Terri, Grunstein, Ron, Fietze, Ingo, Redline, Susan, Azarbarzin, Ali, Sands, Scott A., Schwab, Richard J., Bunck, Mathijs C.

Volltext

Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial von Wadden, Thomas A., Chao, Ariana M., Machineni, Sriram, Kushner, Robert, Ard, Jamy, Srivastava, Gitanjali, Halpern, Bruno, Zhang, Shuyu, Chen, Jiaxun, Bunck, Mathijs C., Ahmad, Nadia N., Forrester, Tammy

Volltext

Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison von Roux, Carel W., Hankosky, Emily R., Wang, Duzhe, Malik, Raleigh, Yu, Maria, Hickey, Ana, Kan, Hong, Bunck, Mathijs C., Stefanski, Adam, Garcia‐Perez, Luis‐Emilio, Wharton, Sean

Volltext

264-OR: Effect of Tirzepatide on Kidney Function in People with Excess Body Weight and Type 2 Diabetes—A Post-Hoc Analysis of the SURMOUNT-2 Trial von HEERSPINK, HIDDO L., FRIEDMAN, ALLON, BJORNSTAD, PETTER, VAN RAALTE, DANIËL, CAO, DACHUANG, GARCIA-PEREZ, LUIS-EMILIO, STEFANSKI, ADAM, TURFANDA, IBRAHIM, BUNCK, MATHIJS C., BENABBAD, IMANE, PIRAS DE OLIVEIRA, CAROLINA, GRIFFIN, RYAN

Volltext

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial von Bunck, Mathijs C, Diamant, Michaela, Cornér, Anja, Eliasson, Bjorn, Malloy, Jaret L, Shaginian, Rimma M, Deng, Wei, Kendall, David M, Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Heine, Robert J

Volltext

1164-P: The Prevalence of Comorbidities among People with Obesity with and without Prediabetes von FORD, JANET, LAGE, MAUREEN J., BOYE, KRISTINA, BAE, JAY P., TERRELL, KENDRA A., BUNCK, MATHIJS C.

Volltext